7.29 USD
↗ 0.55 (8.16%)AT CLOSE (11:59 AM EDT)
Artiva Biotherapeutics, Inc. Common Stock
ARTVNASDAQ • USD
7.27
↘ 0.04 (0.48%)
POST MARKET (AS OF 05:48 PM EDT)
Post Market
AS OF 05:48 PM EDT
7.27
↘ 0.04 (0.48%)
Market: OPEN
Open?$6.99
High?$7.70
Low?$6.88
Prev. Close?$6.74
Volume?349.4K
Avg. Volume?177.2K
VWAP?$7.22
Rel. Volume?1.97x
Bid / Ask
Bid?$5.96 × 100
Ask?$8.29 × 100
Spread?$2.33
Midpoint?$7.13
Valuation & Ratios
Market Cap?166.6M
Shares Out?24.7M
Float?4.0M
Float %?16.4%
P/E Ratio?N/A
P/B Ratio?1.51
EPS?-$3.39
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.61Strong
Quick Ratio?8.61Strong
Cash Ratio?2.04Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.51CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-76.3%WEAK▾
ROA?-64.1%WEAK▾
Cash Flow & Enterprise
FCF?$-79338000
Enterprise Value?$139.9M
Related Companies
Loading...
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Employees
104
Market Cap
166.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
SAN DIEGO, CA 92121
Phone: (858) 267-4467